Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Richelth
- Development stage
- Unknown
- Lead developer
- Charak
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Richelth is a proprietary Ayurvedic formulation developed by Charak Pharma. It is marketed as a multifaceted natural antioxidant, adaptogenic, and anti-aging supplement. The formulation contains a synergistic blend of herbal extracts, including Amalaki (*Emblica officinalis*), Mandukparni (*Centella asiatica*), Marigold (*Calendula officinalis*), Draksha (*Vitis vinifera*), Garlic (*Allium sativum*), and Shunthi (*Zingiber officinale*). Richelth is primarily used to manage oxidative stress, support cognitive function, reduce fatigue, and boost overall immunity.
- Brand names
- Richelth
- Other names
- Richelth CapsuleRichelth Tablets
Beyond the preview
Go deeper on Richelth.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Richelth.